Topic: Avandia
The FDA decision to allow the controversial Avandia diabetes pill on the market - but with tight restrictions - raises as many questions as it answers. Moreover, why did it take more than two months in the US after the FDA advisory ...
FDA notified healthcare professionals and patients that it will significantly restrict the use of the diabetes drug Avandia (rosiglitazone) to patients with Type 2 diabetes who cannot control their diabetes on other medications. Avandia is in a class of drugs known as ...
Two years ago a prominent study revealed that Avandia, a drug used to control blood sugar in diabetics, posed a risk of heart attacks. Then it came out that Avandia's producer, GlaxoSmithKline, hid other data about the risk of heart attacks from ...
The diabetes drug Avandia will no longer be available to patients in Europe and will be restricted in the US over fears it increases the risk of heart attack and strokes, regulators said Thursday.The controversial drug made by British company GlaxoSmithKline would ...
Summary Box: FDA leaves diabetes pill on market with restrictions, Europeans ban salesSPLIT DECISION: U.S. health officials restricted access to the controversial diabetes pill Avandia Thursday, even as European regulators ordered it off the market based on heart attack risks.FORMER BLOCKBUSTER: Avandia ...
The FDA will not ban Avandia -- but stringent restrictions will make it far harder for doctors to prescribe the safety-troubled diabetes drug. "Avandia will be available to new patients only if they cannot achieve [blood sugar] control on other agents and ...
The top US food regulator Thursday severely restricted the use of the controversial diabetes drug, Avandia, made by British firm GlaxoSmithKline, but stopped short of an outright ban.The Food and Drug Administration said in a statement it was taking the step after ...
European regulators ordered the diabetes drug Avandia off the market and the Food and Drug Administration placed stringent restrictions on its use in the United States, saying heart attack risks associated with the former blockbuster are too great a safety concern to ...
European Medicines Agency says diabetes drug Avandia should be pulled from marketEuropean Medicines Agency says diabetes drug Avandia should be pulled from market.In a news briefing on Thursday, the agency said it would suspend its marketing authorizations for the controversial drug which ...
FDA leaves diabetes pill Avandia on market but restricts access due to heart attack risksFederal health regulators will allow GlaxoSmithKline to continue selling a controversial diabetes pill but will restrict access to the once-blockbuster drug because of heart attack risks.The Food and ...
